MedAstra

Medical Weight Management

A serious, sustainable approach to obesity care.

Medical weight management treats obesity as the chronic, complex condition it is — combining clinician oversight, GLP-1 therapy where appropriate, and the daily habits that turn treatment into long-term results.

This page is educational only. It is not medical advice and should not be used to self-prescribe. Suitability for any GLP-1 medication — including semaglutide, Wegovy or tirzepatide — is determined by a qualified clinician based on your full medical history.

How treatment works

From signup to ongoing care, structured.

No guesswork, no medication-by-form. Each step takes minutes and builds on the last.

  1. 01

    Eligibility assessment

    A short structured questionnaire on weight, history and goals — designed to flag whether a clinician review makes sense.

  2. 02

    Lifestyle & health evaluation

    How you eat, sleep, move and work, plus existing conditions — so any plan fits your real life and medical context.

  3. 03

    GLP-1 suitability review

    A qualified clinician reviews your information and discusses whether GLP-1 therapy is appropriate, and what alternatives exist.

  4. 04

    Personalized tracking setup

    Habit anchors, dose-day reminders and a dashboard configured around your specific goal.

  5. 05

    Ongoing progress monitoring

    Side-effect tracking, appetite scores and clinician check-ins so the plan adapts as your body responds.

Medications, explained simply

The therapies your clinician may consider.

Educational overviews only. Eligibility, prescription and dosing are always determined by a qualified clinician based on your medical history.

GLP-1 receptor agonist

Semaglutide

What it is
A once-weekly GLP-1 receptor agonist used in clinical weight management.
How it works
Activates GLP-1 receptors to reduce appetite and lower food intake .
Who it may help
Adults with obesity or weight-related metabolic conditions, after a clinician-led eligibility review.

Always used under qualified medical supervision. Not suitable for everyone.

Read the Semaglutide guide
Branded semaglutide (2.4 mg)

Wegovy

What it is
A branded semaglutide formulation approved specifically for chronic weight management in eligible adults.
How it works
Same GLP-1 mechanism as semaglutide, used at a higher weekly dose dedicated to weight management.
Who it may help
Adults meeting BMI and health criteria, under ongoing medical supervision.

Always used under qualified medical supervision. Not suitable for everyone.

Read the Wegovy guide
Dual GIP + GLP-1 agonist

Tirzepatide

What it is
A dual incretin therapy that activates both GIP and GLP-1 receptors for appetite and metabolic regulation.
How it works
Works on two complementary hormone pathways, often producing more pronounced appetite reduction than GLP-1 alone.
Who it may help
Adults considered eligible by a clinician for advanced metabolic and weight-management support.

Always used under qualified medical supervision. Not suitable for everyone.

Read the Tirzepatide guide

Built responsibly

Medically serious. Quietly confident.

Science-backed approach

Our protocols reference current clinical guidance on GLP-1 therapy and obesity management — not influencer trends.

Doctor-guided care

Eligibility and prescriptions go through qualified clinicians. No pressure to start medication, ever.

Sustainable focus

We design for steady fat loss, typically 0.5–1 kg per week — not viral 30-day transformations.

Responsible education

Clear, plain-language information on benefits, limitations and side effects of GLP-1 therapy.

MedAstra supports lifestyle change alongside clinician-led GLP-1 therapy where appropriate. It does not diagnose, prescribe, or replace qualified medical care. Information on this site is educational and not a substitute for medical advice.

Start with a structured eligibility check.

Start with a structured eligibility check. No commitment, no pressure to begin medication.

Check eligibilityTalk to the assistant